Skip to Main Content

Amazon’s ambitions in health care are now clear: It not only wants to fundamentally change treatment of U.S. patients, it wants a large chunk of the $370 billion market for selling and distributing their prescription drugs.

The company’s acquisition of the home delivery pharmacy PillPack is entirely separate from its venture with JPMorgan Chase and Berkshire Hathaway to improve and lower the cost of care for the companies’ 1 million employees.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!